§ Same category · GLP-1 / metabolic peptides
Semaglutide vs Survodutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Semaglutide
0
vendors tracked
Survodutide
0
vendors tracked
Semaglutide
GLP-1 agonist for metabolic research
No current listings at 5mg.
Survodutide
Glucagon/GLP-1 dual agonist
No current listings at 10mg.
About Semaglutide
A once-weekly GLP-1 receptor agonist studied for glycemic control and weight loss. Approved as a prescription drug in many jurisdictions; research-peptide vendors supply the compound for laboratory use.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.